Proof of concept study to demonstrate the relationship between Improved stability of lipiodol–drug (Idarubicin) emulsion and pharmacokinetic profile for transarterial chemoembolisation of hepatocellular carcinoma.

Trial Profile

Proof of concept study to demonstrate the relationship between Improved stability of lipiodol–drug (Idarubicin) emulsion and pharmacokinetic profile for transarterial chemoembolisation of hepatocellular carcinoma.

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Oct 2016

At a glance

  • Drugs Ethiodized oil (Primary) ; Idarubicin (Primary)
  • Indications Liver cancer
  • Focus Pharmacokinetics; Proof of concept
  • Most Recent Events

    • 27 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top